^
    Back
    Association details:
    Biomarker:MSI2 overexpression
    Cancer:Breast Cancer
    Drug:tamoxifen (Estrogen receptor antagonist)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: C3 – Early Trials
    New
    Source:
    Oncogene
    Title:

    Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer

    Excerpt:
    We further extended the analysis to ER-positive patients who had received endocrine therapy and found that MSI2 levels predicted outcome in patients treated with tamoxifen
    DOI:
    10.1038/onc.2016.327